JPMorgan Starts Mirati Therapeutics (MRTX) at Underweight
Tweet
Share
E-mailGet Alerts MRTX Hot Sheet
Price: $58.70 --0%
Rating Summary:
8 Buy, 18 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Rating Summary:
8 Buy, 18 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Join SI Premium – FREE
JPMorgan analyst Anupam Rama initiates coverage on Mirati Therapeutics (NASDAQ: MRTX) with a Underweight rating and a price target of $85.00.
For an analyst ratings summary and ratings history on Mirati Therapeutics click here. For more ratings news on Mirati Therapeutics click here.
Shares of Mirati Therapeutics closed at $104.46 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CLSA Starts Beijing Easpring Material Technology Co Ltd. (300073:CH) at Outperform (2)
- Canaccord Starts Bubs Australia Ltd (BUB:AU) at Spec. Buy
- CLSA Starts Yunnan Energy New Material Co Ltd (002812:CH) at Outperform (2)
Create E-mail Alert Related Categories
New CoverageRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
